Document:

exv10w74

Exhibit 10.74

REDEMPTION AGREEMENT

     THIS REDEMPTION AGREEMENT (“Agreement”) is made and entered into this 19th day of
February, 2008, by and between QUESTCOR PHARMACEUTICALS, INC., a California corporation
(“Company”) and SHIRE PHARMACEUTICALS, INC., a Delaware corporation
(“Shareholder”).

RECITALS

     A. Shareholder holds of record 2,155,715 shares of the Series A Preferred Stock, no par value,
of the Company (the “Shares”), by way of corporate merger with Roberts Pharmaceuticals
Corporation, previous holder of the Shares.

     B. The Company desires to repurchase the Shares from Shareholder and Shareholder desires to
sell the Shares to the Company, for an aggregate repurchase consideration equal to U.S. $10,347,432
(the “Repurchase Price”) representing a per share price of U.S. $4.80, all on the terms set
forth in this Agreement.

     NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties hereby agree as follows:

AGREEMENT

     1. Repurchase. Shareholder agrees to and does hereby sell, transfer and convey to the
Company the Shares, free and clear of all liens, claims and encumbrances, and the Company agrees to
and does hereby purchase the Shares. In consideration of the sale and transfer of the Shares, and
the waiver and termination of all rights, interests and obligations relating to or arising from
Shareholder’s ownership of the Shares, including any rights, interests and obligations under the
Company’s Articles of Incorporation, and any and all other agreements providing shareholder or
investor rights to which Shareholder is or may be deemed to be a party, and in full payment
therefor, the Company shall pay to Shareholder the Repurchase Price, all on the terms set forth in
this Agreement.

     2. Deliveries. Concurrently with the purchase and sale contemplated by Section 1,
Shareholder shall deliver a duly executed stock power in the form of Exhibit A attached
hereto transferring the Shares to the Company, together with stock certificate A-2 representing the
Shares registered in the name of Shareholder for cancellation and return to the Company’s stock
record book. Against delivery by Shareholder of the executed stock power and the stock certificate
representing the Shares, the Company shall pay the Repurchase Price to Shareholder by wire transfer
in immediately available funds. Shareholder has provided the correct wire transfer instructions to
effect the wire transfer to the Company.

     3. Representations, Warranties and Covenants of Shareholder. Shareholder hereby
represents, warrants and covenants to the Company as follows:

 

 

          (a) Legal Power. Shareholder has the requisite legal power and authority to enter
into this Agreement, to deliver the Shares and to carry out and perform its obligations under the
terms of this Agreement, without obtaining the approval or consent of any other party or authority.

          (b) Title to Shares. Shareholder owns the Shares free and clear of all liens,
charges, claims, encumbrances, security interests, equities, restrictions on transfer or other
defects in title of any kind or description and, upon delivery of the Shares and receipt of the
Repurchase Price therefor, Shareholder will convey to the Company valid and marketable title to the
Shares, free and clear of all liens, charges, claims, encumbrances, security interests, equities,
restrictions on transfer or other defects in title or description.

          (c) Investment Representations.

               (i) Shareholder is a company in the pharmaceutical industry. Due to Shareholder’s
pharmaceutical experience, including its experience in maintaining and divesting equity positions
in other pharmaceutical companies, Shareholder possesses the expertise to be able to fend for
itself in the transaction contemplated by this Agreement, and is capable of evaluating and bearing
the risks and merits of selling the Shares for the Repurchase Price and pursuant to the terms of
this Agreement.

               (ii) Shareholder has had, during the course of this transaction and prior hereto, the
opportunity to ask questions of, and receive answers from, the Company and its management
concerning the Company, its operations and prospects, and the terms and conditions of this
Agreement.

               (iii) Shareholder believes that it has received all such information as it considers necessary
for evaluating the risks and merits of selling the Shares for the Repurchase Price and pursuant to
the terms of this Agreement and for verifying the accuracy of any information furnished to it or to
which it had access.

               (iv) Neither the Company, nor any affiliate of the Company, has made any representations or
warranty, express or implied, regarding any aspect of the transaction except as set forth herein
this Agreement, and Shareholder is not relying on any such representation or warranty not contained
in this Agreement.

               (v) Shareholder acknowledges that this Agreement is being entered into during a regularly
scheduled trading black-out under the Company’s Insider Trading Compliance Program and that the
Company may possess or have access to material non-public information which has not been
communicated to Shareholder.

          (d) Acceptance of Risk. Shareholder is entering into this Agreement freely and
understands and expressly accepts and assumes the economic and market risk associated with selling
the Shares for the Repurchase Price and agrees that this Agreement shall be in all respects
effective and not subject to termination or rescission under any circumstances.

          (e) Tax Consequences. Shareholder acknowledges that the Company is making no
representation or warranty as to the tax consequences for Shareholder in selling the Shares for the
Repurchase Price pursuant to this Agreement. Shareholder further acknowledges that it has had an
opportunity to seek independent counsel and advisors with respect to tax and other matters relating
to

2

 

this Agreement, and Shareholder acknowledges and agrees that it shall bear the full tax
consequences, if any, of selling the Shares for the Repurchase Price and pursuant to the terms of
this Agreement in all circumstances.

          (f) US Person. Shareholder is a “United States person” within the meaning of Section
7701(a)(30) of the Internal Revenue Code of 1986 as amended.

          (g) Indemnification Covenant. Shareholder is aware that the Company is relying upon
the truth of the foregoing representations in this Section 3 in connection with the transaction.
Shareholder shall indemnify, protect, defend and hold free and harmless the Company from and
against all losses resulting from the defense, settlement or compromise of a claim or demand or
assessment incurred by the Company as a result of any breach by Shareholder of any of its
representations, warranties or covenants contained in this Agreement.

     4. Company Representations. Company represents and warrants to Shareholder that this
Agreement has been duly executed and delivered by the Company and constitutes a legal, valid and
binding obligation of the Company enforceable against the Company in accordance with its terms.

     5. Mutual Release.

     (a) Except for the duties, obligations and representations set forth in this Agreement, the
parties hereto hereby release, discharge and acquit each other, as well as, to the extent
applicable, their respective officers, directors, shareholders, partners, employees, agents,
successors and assigns, and any parent, subsidiary or affiliated entity, past, present, or future,
from any and all claims, demands, costs, contracts, liabilities, objections, actions and causes of
action of every nature, whether in law or in equity, known or unknown, suspected or unsuspected,
which the parties ever had or now have or may claim to have against each other of any type, nature
or description prior to the execution and delivery hereof with respect to or arising from the
purchase or ownership of the Shares by Shareholder. In addition, Shareholder waives any and all
claims it may have or may hereafter acquire against the Company, relating to any failure to
disclose non-public information in connection with the transaction.

     (b) Waiver of §1542 – Each of the parties acknowledges that each is aware that they may
hereafter discover facts different from or in addition to what such party knows or believes to be
true with respect to the matters released in this Agreement. Each of the parties agrees and
acknowledges that the releases granted herein are general releases as to all matters released in
this Agreement. Each of the parties acknowledges that such party has been informed of Section 1542
of the Civil Code of the State of California, and does hereby expressly waive and relinquish all
rights and benefits which such Party has or may have under that Section, which reads as follows:

“A general release does not extend to claims which the
creditor does not know or suspect to exist in his or her favor at the
time of executing the release, which if known by him or her must
have materially affected his or her settlement with the debtor..”

          6. Miscellaneous.

          (a) Entire Agreement. This Agreement represents and contains the full, final and
complete agreement and understanding between the parties hereto relating to or connected with the

3

 

subject matter hereof. Notwithstanding the foregoing, each party agrees that, at any time and from
time to time after the date hereof, it will take any and all actions and execute and deliver to any
other party such further instruments or documents as may reasonably be required to give effect to
the intentions of the parties as contemplated under this Agreement. This Agreement shall not be
amended except in a writing signed by the parties hereto.

          (b) Governing Law and Venue. This Agreement was entered into in the State of
California, and its validity, construction, interpretation and legal effect shall be governed by
the laws and judicial decisions of the State of California applicable to contracts entered into and
performed entirely within the State of California and by applicable federal law, and the
choice-of-law provisions of California law shall not be applied to substitute the law of any other
State or nation. The parties expressly agree that any action arising out of or relating to this
Agreement shall be filed and maintained only in the courts of the State of California for the
County of Alameda, or the United States District Court for the Northern District of California.
The parties hereby consent and submit to the personal jurisdiction of such courts for the purposes
of litigating any such action, and that each such court is a proper venue for litigating any such
action. Notwithstanding the foregoing, each party agrees that in the event that a party hereto
(the “Involved Party”) becomes involved in any legal action with a third party, and either:
(i) the other party hereto (the “Non-involved Party”) is a necessary party to the
resolution of such legal action, or (ii) the particular legal action gives rise to legal claims
between the parties hereto arising out of or relating to this Agreement, then the Non-involved
Party will submit to the personal jurisdiction of the court in which such action is maintained, and
action to resolve such legal claims between the parties may be brought or maintained in the same
court in which the legal action involving the third party is maintained.

          (g) Severability. In the event that any of the provisions of this Agreement shall be
held by a court or other tribunal of competent jurisdiction to be unenforceable, the remaining
portions of this Agreement shall remain in full force and effect.

          (h) Attorneys’ Fees. In the event that either party to this Agreement shall commence
any action to interpret or enforce this Agreement or any action to enforce or appeal any decision
or judgment rendered in connection therewith, the party in any such action or actions shall recover
such party’s reasonable costs and expenses incurred in connection therewith, including reasonably
attorneys’ fees.

          (i) Specific Performance. Shareholder acknowledges that money damages would not be a
sufficient remedy for any breach of this Agreement and that irreparable harm would result if this
Agreement were not specifically enforced. Therefore, the rights of the Company and the obligations
of Shareholder under this Agreement shall be enforceable by a decree of specific performance issued
by any court of competent jurisdiction, and appropriate injunctive relief may be applied for and
granted in connection therewith. The Company’s right to specific performance shall be in addition
to all other legal or equitable remedies available to the Company.

          (j) Headings. The headings of the Sections and subsections contained in this
Agreement are for reference purposes only, and shall not affect the meaning or interpretation of
this Agreement.

          (k) Counterparts. This Agreement may be executed in two or more counterparts, which
shall together constitute one and the same agreement.

4

 

     IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first written
above.

	 	 	 	 	 	 	 	 	 
	“COMPANY”	 	“SHAREHOLDER”	 	 
	 
	 	 	 	 	 	 	 	 
	QUESTCOR PHARMACEUTICALS, INC.

a California corporation	 	SHIRE PHARMACEUTICALS, INC.

a Delaware corporation	 	 
	 
	 	 	 	 	 	 	 	 
	/s/ George M. Stuart	 	 	 	/s/ Scott Applebaum	 	 
	 	 	 	 	 	 	 
	George M. Stuart

	 	 	 	BY:
	 	Scott Applebaum	 	 
	Senior Vice President, Finance

	 	 	 	ITS:
	 	Secretary	 	 
	and Chief Financial Officer
	 	 	 	 	 	 	 	 

5

 

EXHIBIT A

STOCK ASSIGNMENT SEPARATE FROM CERTIFICATE

     FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto QUESTCOR
PHARMACEUTICALS, INC., a California corporation (the “Company”), 2,155,715 shares of the
Series A Preferred Stock, no par value, of the Company, standing in the undersigned’s name on the
books of the Company, represented by Certificate No. A-2 herewith, and does hereby irrevocably
constitute and appoint George M. Stuart, as attorney-in-fact, to transfer said stock on the books
of the Company with full power of substitution in the premises.

	 	 	 	 	 	 	 	 	 
	Dated: 19 February, 2008	 	 	 	/s/ Scott Applebaum	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	SHIRE PHARMACEUTICALS, INC.	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	BY:
	 	Scott Applebaum	 	 
	 

	 	 	 	 	 	 	 	 
	 

	 	 	 	ITS:
	 	Secretaryexv10w75

Exhibit 10.75

SEVERANCE AGREEMENT

     SEVERANCE AGREEMENT (this “Agreement”), dated as of September 10, 2008 (the “Effective Date”),
between Questcor Pharmaceuticals, Inc., a California corporation (the “Company”), and Gary Sawka
(“Executive”).

W I T N E S S E T H:

     WHEREAS, Executive is being employed by the Company pursuant to an Offer Letter dated
September 9, 2008, and the Company and Executive desire to enter into this Agreement to set forth
the terms on which Executive may be entitled to severance benefits from the Company.

     NOW, THEREFORE, in consideration of the mutual covenants herein contained, the Company and
Executive hereby agree as follows:

     1. At-Will Nature of Employment.

     (a) Termination of Employment. The Company may terminate Executive’s employment at
any time with or without Cause effective immediately upon delivery of a Notice of Termination to
Executive. Subject to the immediately following sentence and for purposes of this Agreement only,
“Cause” shall mean with respect to Executive, any of the following: (i) Executive’s material
neglect of assigned duties with the Company or Executive’s failure or refusal to perform assigned
duties with the Company, which continues uncured for thirty (30) days following receipt of written
notice of such deficiency from the Board of Directors of the Company (“Board”), specifying the
scope and nature of the deficiency; (ii) Executive’s commission of a felony or fraud; or
Executive’s misappropriation of property belonging to the Company or its affiliates;
(iii) Executive’s commission of a misdemeanor or act of dishonesty, which causes material harm to
the Company; (iv) Executive’s engaging in any act of moral turpitude which causes material harm to
the Company; (v) Executive’s breach of the Company’s trading compliance program or any
confidentiality, proprietary information or nondisclosure agreement with the Company; or
(vi) Executive’s working for another company, partnership or other entity, whether as an employee,
consultant or director, while an employee of the Company without the prior written consent of the
Board. Any determination of Cause as used herein will be made in good faith by the Board. A
termination by the Company for reasons other than set forth in clauses (i) through (vi) above, or
for no reason at all but not including a termination of Executive’s employment with the Company as
a result of death or Disability, shall be deemed a “Termination Without Cause.”

     (b) Voluntary Termination by Executive. Executive may voluntarily terminate his
employment with the Company upon 30 days written notice to the Company.

 

 

     (c) Termination by Executive for Good Reason. Executive may terminate his employment
with the Company for Good Reason. “Good Reason” shall mean the occurrence, without Executive’s
written consent, of one or more of the following events: (i) the Company materially decreases
Executive’s responsibilities, or (ii) the Company breaches the terms of this Agreement; provided
that no such event shall constitute Good Reason hereunder unless (a) Executive shall have given
written notice to the Company of Executive’s intent to resign for Good Reason within 30 days after
Executive becomes aware of the occurrence of any such event (specifying in detail the nature and
scope of the event) and (b) such event or occurrence shall not have been resolved to Executive’s
reasonable satisfaction within 30 days of the Company’s receipt of such notice.

     (d) Notice of Termination. Any termination of Executive’s employment by the Company
or by Executive shall be communicated by a written Notice of Termination addressed to Executive or
the Company, as applicable. Termination may be effective immediately upon communication of such
Notice of Termination. A “Notice of Termination” shall mean a notice stating that Executive’s
employment with the Company has been or will be terminated and the specific provisions of this
Section 1 under which such termination is being effected.

     (e) Payments Upon Termination. Upon termination of Executive’s employment for any
reason, the Company shall pay Executive (i) his Base Salary earned but not yet paid for services
rendered to the Company on or prior to the date on which the Employment Period ends, (ii) any
accrued but unused vacation days, (iii) any incurred but unpaid reimbursable business expenses and
other insurance related reimbursable expenses, and (iv) any amounts required under the Company’s
Employee Stock Purchase Plan (or successor plans).

     2. Payments Upon Certain Terminations Not Involving a Change in Control.

     (a) Termination by the Company Without Cause or Termination by Executive for Good
Reason. In addition to the payments described in Section 1(e) and subject to Section 4,
provided that Executive is in compliance with his obligations under his Proprietary Information and
Inventions Agreement with the Company, in the event Executive’s employment is terminated by the
Company Without Cause or by Executive for Good Reason, the Company shall (i) pay Executive any
annual bonus payable for services rendered in any annual bonus period for the year which had been
completed in its entirety prior to the date on which the Employment Period ends and that had not
previously been paid, (ii) continue to make Base Salary payments for (A) a period 6 months
following such termination of employment if the termination occurs on or before the third
anniversary of the date on which Executive commenced employment with the Company, or (B) a period
12 months following such termination of employment if the termination occurs after such third
anniversary date (the period of time such payments are provided, the “Severance Period”), payable
in accordance with the Company’s payroll practices as in effect on such termination date, except
that such continued Base Salary payments shall not commence until the first payroll date following
the effective date of the Release Agreement referenced in Section 4, and the first continued Base
Salary payment shall cover the period between the termination date and such payment. Each
installment payment made pursuant to this Section 2(a)(ii) shall be considered a separate payment
for purposes of Section 409A of the Internal Revenue Code of 1986 (the “Code”).

2

 

     (b) Duty to Mitigate. If Executive is reemployed for at least twenty (20) hours per
week on average at any time after the termination date and before the end of the Severance Period,
Executive shall promptly provide written notice to the Company of such reemployment, and all
further severance compensation payments under this Section 2 shall be decreased by the amount of
the annual compensation received by Executive from the new employer.

     3. Payments Upon Certain Terminations Involving a Change in Control.

     (a) Statement of Intent. The Board recognizes that, as is the case with many publicly
held corporations, the possibility of a change in control of the Company may exist and that the
uncertainty and questions that it may raise among management could result in the departure or
distraction of management personnel to the detriment of the Company and its shareholders.
Accordingly, the Board has decided to reinforce and encourage Executive’s attention and dedication
to Executive’s assigned duties without the distraction arising from the possibility of a change in
control of the Company.

     (b) Accelerated Vesting. Notwithstanding anything to the contrary in the Company’s
1992 Employee Stock Option Plan or its 2006 Equity Incentive Award Plan (the “Option Plans”), in
the event that a Change in Control (as defined in the Option Plans) occurs, and Executive’s
employment with the Company is terminated by the Company Without Cause or by Executive for Good
Reason at any time within the three (3) month period before the date of such Change in Control or
during the twelve (12) month period following the date of such Change in Control, one-hundred
percent (100%) of the then-unvested shares of Questcor’s common stock subject to each of
Executive’s outstanding stock options and one-hundred percent (100%) of Executive’s restricted
shares subject to vesting will become immediately vested and exercisable on the date of such
termination.

     (c) Cash Severance Upon Termination Without Cause or for Good Reason. In the event
that a Change in Control occurs, and Executive’s employment with the Company is terminated by the
Company Without Cause or by Executive for Good Reason at any time within the three (3) month period
before the date of such Change in Control or during the twelve (12) month period following the date
of such Change in Control, Executive will receive severance compensation equal to the sum of (i) an
amount equal to his highest Base Salary in the calendar year in which the Change in Control occurs,
plus (ii) an amount equal to his target bonus as established by the Board or its Compensation
Committee for the year during which the termination takes place (or if such target bonus has not
yet been established, the target bonus for the prior year).

     (d) Payment Administration. The severance payment under Section 3(c) shall be made in
a single lump sum on the release effective date of the Release Agreement referenced in Section 4.
Payments under Section 3(c) shall be in addition to the payments under Section 1(e) but shall be in
lieu of, and not in addition to, the payment of any cash severance payments that Executive may
otherwise be entitled to under Section 2 of this Agreement.

     (e) No Duty to Mitigate. Executive’s reemployment at any time following the
termination of Executive’s employment shall have no effect on his right to collect severance under
this Section 3.

3

 

     4. Release.

     (a) Execution of Release. As a condition of Executive’s right to receive the payments
described in Sections 2(a) and 3(c), Executive shall within 21 days following Executive’s
termination of employment (or within 45 days if Executive is terminated as part of a group layoff)
execute and deliver to the Company a full and complete release of all claims, known and unknown,
that Executive may have against the Company and its related past and present entities, officers,
directors, shareholders, agents, representatives, successors and employees, such release to be
substantially in the form of the release attached hereto as Exhibit A (the “Release
Agreement”); provided, however, that any conflict between the terms of this Agreement and such form
of release attached as Exhibit A shall be resolved in favor of this Agreement.

     (b) Effect of Failure. In the event Executive fails to deliver or revokes the release
referred to in Section 4(a) above, Executive shall not be entitled to any of the payments described
in Section 2(a) or 3(c) above. In the event that, prior to the end of the Severance Period,
Executive breaches any of his obligations under this Agreement, including this Section 4, the
Company’s obligations to provide the payments under Sections 2(a) and 3(c) shall thereupon cease
and the Company shall be entitled to recover from Executive any and all amounts theretofore paid to
Executive pursuant to Section 2(a) or 3(c).

     5. Death and Disability. In the event the Executive’s employment at the Company ends
as a result of Executive’s death, this Agreement shall automatically terminate and Executive’s
estate shall be entitled to receive (i) the amounts described in Section 1(e), and (ii) any annual
bonus payable for services rendered in any annual bonus period for the year which had been
completed in its entirety prior to the date on which the Employment Period ends and that had not
previously been paid. The bonus amount under clause (ii) will be payable to Executive’s estate
when and if such annual bonuses would otherwise have been payable. In the event of Executive’s
Disability, the Company shall have the right to terminate this Agreement and Executive’s employment
immediately. Additionally, Executive shall be entitled to his annual bonus as described under
clause (ii) above, except that the payments shall be to Executive and not his estate.

     6. Miscellaneous.

     (a) Survival. To the extent necessary to give effect to such provisions, the
provisions of this Agreement shall survive the termination hereof, whether such termination shall
be by expiration of the Employment Period or otherwise.

     (b) Binding Effect. This Agreement shall be binding on, and shall inure to the
benefit of, the Company and any person or entity that succeeds to the interest of the Company
(regardless of whether such succession occurs by operation of law) by reason of the sale of all or
a portion of the Company’s equity securities, a merger, consolidation or reorganization involving
the Company or, unless the Company otherwise elects in writing, a sale of all or a portion of the
assets of the business of the Company. This Agreement shall also inure to the benefit of
Executive’s heirs, executors, administrators and legal representatives.

4

 

     (c) Assignment. Executive may not assign this Agreement. The Company may assign its
rights, together with its obligations, under this Agreement (i) to any affiliate or subsidiary or
(ii) to third parties in connection with any sale, transfer or other disposition of all or
substantially all of its business or assets.

     (d) Entire Agreement. This Agreement constitutes the entire agreement between the
parties hereto with respect to the matters referred to herein and supersedes any and all prior
agreements, whether written or oral. There are no promises, representations, inducements or
statements between the parties other than those that are expressly contained herein. Executive
acknowledges that he is entering into this Agreement of his own free will and accord, and with no
duress, that he has read this Agreement and that he understands it and its legal consequences.

     (e) Severability; Reformation. In the event that one or more of the provisions of
this Agreement is or shall become invalid, illegal or unenforceable in any respect, the validity,
legality and enforceability of the remaining provisions contained herein shall not be affected
thereby. In the event any covenant contained herein is not enforceable in accordance with its
terms, including, but not limited to, if found to be excessively broad as to duration, scope,
activity or subject, Executive and the Company agree that such covenant shall be reformed to make
it enforceable in a manner that provides as nearly as possible the result intended by this
Agreement so as to be enforceable to the maximum extent compatible with applicable law.

     (f) Waiver. Waiver by any party hereto of any breach or default by the other party of
any of the terms of this Agreement shall not operate as a waiver of any other breach or default,
whether similar to or different from the breach or default waived. No waiver of any provision of
this Agreement shall be implied from any course of dealing between the parties hereto or from any
failure by either party hereto to assert its or his rights hereunder on any occasion or series of
occasions.

     (g) Notices. Any notice required or desired to be delivered under this Agreement
shall be in writing and shall be delivered personally, by courier service, by registered mail,
return receipt requested, or by email and shall be effective upon actual receipt by the party to
which such notice shall be directed, and shall be addressed as follows (or to such other address as
the party entitled to notice shall hereafter designate in accordance with the terms hereof):

If to the Company:

Questcor Pharmaceuticals, Inc.

Attention: Chairman of the Board of Directors

3260 Whipple Road

Union City, California 94587

If to Executive:

To the most recent address of the Executive set forth in the personnel records
of the Company.

     (h) Amendments. This Agreement may not be altered, modified or amended except by a
written instrument signed by each of the parties hereto.

5

 

     (i) Headings. Headings to sections in this Agreement are for the convenience of the
parties only and are not intended to be part of or to affect the meaning or interpretation hereof.

     (j) Counterparts. This Agreement may be executed in counterparts, each of which shall
be deemed an original but all of which together shall constitute one and the same instrument.

     (k) Withholding. Any payments provided for herein shall be reduced by any amounts
required to be withheld by the Company under applicable Federal, State or local income or
employment tax laws or similar statutes or other provisions of law then in effect.

     (l) Disputes. Any and all disputes connected with, relating to or arising from
Executive’s employment with the Company, this Agreement, or the Release attached as Exhibit A, will
be settled by final and binding arbitration in accordance with the rules of the American
Arbitration Association as presently in force. The only claims not covered by this Agreement are
claims for benefits under the unemployment insurance or workers’ compensation laws. Any such
arbitration will take place in Alameda County, California. The parties hereby incorporate into
this agreement all of the arbitration provisions of Section 1283.05 of the California Code of Civil
Procedure. The Company understands and agrees that it will bear the costs of the arbitration
filing and hearing fees and the cost of the arbitrator. Each side will bear his/its own attorneys’
fees, and the arbitrator will not have authority to award attorneys’ fees unless a statutory
section at issue in the dispute authorizes the award of attorneys’ fees to the prevailing party, in
which case the arbitrator has authority to make such award as permitted by the statute in question.
The arbitration shall be instead of any civil litigation; this means that Executive is waiving any
right to a jury trial, and that the arbitrator’s decision shall be final and binding to the fullest
extent permitted by law and enforceable by any court having jurisdiction thereof. Judgment upon
any award rendered by the arbitrators may be entered in any court having jurisdiction.

     (m) Governing Law. This Agreement shall be governed by the laws of the State of
California, without reference to principles of conflicts or choice of law under which the law of
any other jurisdiction would apply.

     (n) Representation. Executive acknowledges that Stradling Yocca Carlson & Rauth
represents the Company and Executive has neither sought nor received legal advice from Stradling
Yocca Carlson & Rauth in connection with this Agreement.

[SIGNATURE PAGE FOLLOWS]

6

 

     IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly
authorized officer and Executive has hereunto set his hand as of the day and year first above
written.

	 	 	 	 	 
	 	Questcor Pharmaceuticals, Inc.

 	 
	 	By:  	/s/ Don Bailey
 	 
	 	 	Name:  	Don Bailey 	 
	 	 	Title:  	President and Chief Executive Officer 	 
	 
	 	Executive

 	 
	 	By:  	/s/ Gary Sawka
 	 
	 	 	Name:  	Gary Sawka 	 
	 	 	 	 

7

 

	 	 	 	 	 

EXHIBIT A

Form of Release

SEPARATION AGREEMENT AND GENERAL RELEASE

                         , on behalf of himself and his heirs, successors, and assigns (the “Executive”) and
Questcor Pharmaceuticals, Inc. (the “Company”) hereby agree to the following terms and conditions
related to the recent termination of Executive’s employment with the Company.

     1. Executive’s employment with the Company ceased effective                      (the “Termination
Date”). Effective as of that date, Executive (a) relinquished his title[s] of
                                         of the Company, as well as any other officer or employee positions or
titles he may have held with the Company and any of its affiliated companies, and (b) [if
applicable] resigned as a director of the Company and any of its affiliated companies.

     2. With respect to any outstanding business expenses, Executive agrees that on or before
                    , he will submit a final expense reimbursement statement reflecting any outstanding
business expenses incurred through his Termination date, along with the appropriate receipts and
necessary supporting documentation. The Company will provide reimbursement pursuant to its current
business policies and practices for all reasonable and appropriate business expenses.

     3. Other than any outstanding business expenses and the future payments referenced in
Paragraph 5 below, Executive represents and agrees that he has received all compensation owed to
him by the Company through his Termination Date, including any and all wages, bonuses, incentives,
stock options, commissions, earned but unused vacation, and any other payments, benefits, or other
compensation of any kind to which he was entitled from the Company.

     4. Executive represents to the Company that he is signing this Separation Agreement and
General Release (this “Agreement”) voluntarily and with a full understanding of and agreement with
its terms for the purpose of receiving additional pay and consideration from the Company beyond
that which is owed to him.

     5. Conditioned on Executive’s execution, without subsequent revocation, of this Separation
Agreement and General Release and Executive’s compliance with the terms of this Agreement, the
Company will provide Executive with the consideration in accordance with Section 2(a) and Section
3(c) of the Severance Agreement between Executive and the Company dated                     , 2008
commencing either eight (8) days after the Company’s receipt of this Separation Agreement and
General Release executed by Executive (the “Release Effective Date”) or as soon thereafter as
administratively practicable.

     6. Upon Executive’s eligibility for health insurance coverage through other employment during
the Severance Period, all insurance premium payments by the Company for Executive and his currently
insured dependents under COBRA shall cease. Other than what is specified in the Employment
Agreement, Executive will not accrue or be entitled to receive any other compensation or benefits,
including but not limited to, vacation, holiday pay, car allowance, etc., during the Severance
Period.

A-1

 

     7. Should Executive fail to execute this Agreement within the time frame provided or should
Executive subsequently revoke or breach this Agreement, this Agreement will immediately become null
and void, no consideration will due or payable, and any and all consideration provided under this
Separation Agreement must be immediately returned.

     8. Executive understands that nothing in this Separation Agreement supersedes his continuing
obligations under the Company’s [Proprietary Information and Inventions Agreement, Policy Against
Insider Training, Confidentiality Agreement, Non-Disclosure Agreement, etc.] which he signed during
his employment, all of which will remain in full force and effect as these documents contain
obligations which continue after the effective date of his termination. Executive agrees to comply
with all such continuing obligations.

     9. In exchange for the consideration described above, which Executive would not otherwise be
entitled to receive, Executive does hereby forever irrevocably and unconditionally fully release
and discharge the Company and its parents, subsidiaries, and affiliates, together with their past
and current officers, directors, agents, employees, partners, shareholders and representatives
(hereinafter collectively referred to as the “Released Parties”) from any and all causes of action,
claims, suits, demands or other obligations or liabilities of every kind and nature (including
without limitation attorneys’ fees and costs), whether known or unknown, that Executive ever had,
now has, or may in the future have that arose on or before the date Executive signs this Agreement,
including but not limited to all claims regarding any aspect of his employment, compensation, or
the termination of his employment with the Company, his offer letter from the Company, the Age
Discrimination in Employment Act of 1967, the Americans with Disabilities Act of 1990, Title VII of
the Civil Rights Act of 1964, 42 U.S.C. section 1981, the Fair Labor Standards Acts, the WARN Act,
the Sarbanes-Oxley Act, the California Fair Employment and Housing Act, California Government Code
section 12900, et seq., the Unruh Civil Rights Act, California Civil Code section 51, all
provisions of the California Labor Code; the Employee Retirement Income Security Act, 29 U.S.C.
section 1001, et seq., all as amended, any other federal, state or local law, regulation or
ordinance or public policy, contract, tort or property law theory, or any other cause of action
whatsoever that arose on or before the date Executive signs this Agreement. Executive’s release
contained herein shall not include any release of any rights, claims or entitlements Executive has
or may have to indemnification under any Indemnification Agreement he entered into with the Company
or pursuant to the Company’s Articles of Incorporation or any coverage Executive may have under the
Company’s directors and officers insurance policy for acts and omissions occurring within the
course and scope of Executive’s employment while acting as an officer or director of the Company.

     10. It is further understood and agreed that as a condition of this Agreement, all rights
under Section 1542 of the Civil Code of the State of California are expressly waived by Executive.
Such Section reads as follows:

“A general release does not extend to claims which the creditor does
not know or suspect to exist in his or her favor at the time of
executing the release, which if known by him or her must have
materially affected his or her settlement with the debtor.”

A-2

 

          Thus, for the purpose of implementing a full and complete release and discharge of the
Released Parties, Executive expressly acknowledges that this Agreement is intended to include and
does include in its effect, without limitation, all claims which Executive does not know or suspect
to exist in his favor against the Released Parties at the time of execution hereof, and that this
Agreement expressly contemplates the extinguishment of all such claims.

     11. Executive agrees to withdraw with prejudice all complaints or charges, if any, he has
filed against any of the Released Parties with any agency or court. Executive agrees that he will
not file any lawsuit, complaint, or charge against any Released Party based on the claims released
in this Separation Agreement and General Release.

     12. The release in this Agreement includes, but is not limited to, claims arising under
federal, state or local law for age, race, sex or other forms of employment discrimination and
retaliation. In accordance with the Older Workers Benefit Protection Act, Executive hereby
knowingly and voluntarily waives and releases all rights and claims, known or unknown, arising
under the Age Discrimination in Employment Act of 1967, as amended, which he might otherwise have
had against the Released Parties. Executive is hereby advised that he should consult with an
attorney before signing this Agreement and that he has 21 days in which to consider and accept this
Agreement by signing and returning this Agreement to the Chairman of the Company’s Compensation
Committee. In addition, Executive has a period of seven days following his execution of this
Agreement in which he may revoke the Agreement. If Executive does not advise the Chairman of the
Compensation Committee by a writing received by him within such seven day period of Executive’s
intent to revoke the Agreement, the Agreement will become effective and enforceable upon the
expiration of the seven days.

     13. Executive acknowledges that this Agreement may be filed by the Company with the Securities
and Exchange Commission in accordance with the Company’s filing obligations under the Securities
Exchange Act of 1934.

     14. Executive represents that he has returned to the Company all proprietary or confidential
information and property of the Company, including but not limited to any Company owned or leased
laptop computer, all keys to the office and leased automobile, all fobs, credit cards, files,
records, access cards, equipment and other Company owned property, records or information in his
possession, including all copies thereof in whatever form, including any and all electronic copies,
and has destroyed all electronic copies of all proprietary or confidential information of the
Company.

     15. Executive acknowledges that he is aware of his obligations under the federal securities
laws relating to trading in the Company’s securities while in possession of material, non-public
information about the Company. Executive further acknowledges that he is aware of his reporting
obligations under Section 16(a) of the Securities Exchange Act of 1934 and that he has properly and
timely filed all forms required by such Section.

     16. Any and all disputes connected with, related to or arising from this Separation Agreement
and General Release will be settled by final and binding arbitration in accordance with the rules
of the American Arbitration Association as presently in force. Any such arbitration will take
place in Alameda County, California. The parties hereby incorporate into

A-3

 

this agreement all of the arbitration provisions of Section 1283.05 of the California Code of
Civil Procedure. The Company understands and agrees that it will bear the costs of the arbitration
filing and hearing fees and the cost of the arbitrator. Each side will bear his/its own attorneys’
fees, and the arbitrator will not have authority to award attorneys’ fees unless a statutory
section at issue in the dispute authorizes the award of attorneys’ fees to the prevailing party, in
which case the arbitrator has authority to make such award as permitted by the statute in question.
The arbitration shall be instead of any civil litigation; this means that you are waiving any
right to a jury trial, and that the arbitrator’s decision shall be final and binding to the fullest
extent permitted by law and enforceable by any court having jurisdiction thereof. Judgment upon
any award rendered by the arbitrators may be entered in any court having jurisdiction.

     17. This Separation and General Release shall not be construed against any party merely
because that party drafted or revised the provision in question, and it shall not be construed as
an admission by the Released Parties of any improper, wrongful, or unlawful actions, or any other
wrongdoing against Executive, and the Released Parties specifically disclaim any liability to or
wrongful acts against Executive.

     18. This Agreement may be modified only by written agreement signed by both parties.

     19. In the event any provision of this Agreement is void or unenforceable, the remaining
provisions shall continue in full force and effect.

     20. This Separation Agreement and General Release, along with the above-mentioned
[Confidentiality, Indemnification, and Non-Disclosure Agreements between Company and Executive],
all of which are incorporated herein by this reference, constitute the entire agreement between the
parties regarding the subject matter hereof, and supersede any and all prior and contemporaneous
oral and written agreements. Executive acknowledges and agrees that he is not relying on any
representations or promises by any representative of the Company regarding any term not included in
this Agreement or concerning the meaning of any aspect of this Release Agreement.

     21. This Separation Agreement and General Release may be executed in one or more counterparts
and by facsimile or email, each of which shall be deemed an original but all of which shall
constitute a single document.

	 	 	 	 	 	 	 
	 	 	 	 	EXECUTIVE
	 
	 	 	 	 	 	 
	Dated:
	 	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	[Name]
	 
	 	 	 	 	 	 
	 	 	 	 	QUESTCOR PHARMACEUTICALS, INC.
	 
	 	 	 	 	 	 
	Dated:

	 	 	 	By:	 	 
	 

	 	 
	 	 
	 	 

A-4

 

EXHIBIT B

CALIFORNIA LABOR CODE SECTION 2870

“(a) Any provision in an employment agreement which provides that an employee shall assign, or
offer to assign, any of his or her rights in an invention to his or her employer shall not apply to
an invention that the employee developed entirely on his or her own time without using the
employer’s equipment, supplies, facilities, or trade secret information except for those inventions
that either:

          (1) Relate at the time of conception or reduction to practice of the invention to the
employer’s business, or actual or demonstrably anticipated research or development of the employer;
or

          (2) Result from any work performed by the employee for the employer.

(b) To the extent a provision in an employment agreement purports to require an employee to assign
an invention otherwise excluded from being required to be assigned under subdivision (a), the
provision is against the public policy of this state and is unenforceable.”

B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}]]